Universal reference book for medicines
Product name: OCTILIA (OCTILIA)

Active ingredient: tetryzoline

Type: The drug with vasoconstrictive action for topical application in ophthalmology

Manufacturer: SIFI (Italy) official distributor in Russia ZAMBON (Italy)
Composition, form of production and packaging
Drops of eye
colorless or light yellow color, transparent.

1 ml

tetrisoline hydrochloride 500 Ојg

Excipients: benzalkonium chloride, disodium phosphate decahydrate, potassium dihydrogen phosphate, sodium chloride, sodium edetate, distilled water, distilled chamomile water, distilled lime water, polysorbate 80, purified water.

8 ml - a bottle-droppers polyethylene (1) - packs cardboard.


Description of the drug approved by the manufacturer for the printed edition of 2005.


The drug with vasoconstrictive action for topical application in ophthalmology.
Tetrizoline hydrochloride is an alpha-adrenomimetic, an imidazole derivative. Has pronounced vasoconstrictive effect, reduces edema and flushing of mucous membranes.
Extracts of chamomile and lime have an anti-inflammatory effect.


- as part of complex therapy for the treatment of eye diseases accompanied by irritation symptoms caused by allergic, chemical and physical factors (smoke, dust, strong light, reflection of light from snow and water surfaces, from radiating screens of monitors).


The drug is instilled in 1-2 drops in the lower conjunctival sac 2-3 times / day.


Local reactions: mydriasis, increased intraocular pressure, burning sensation, reactive conjunctival hyperemia.

Systemic reactions: headache, nausea, drowsiness, weakness, tremor, dizziness, insomnia, palpitation, tachycardia, hyperglycemia, increased blood pressure, cardiac dysfunction, allergic reactions.


- glaucoma;

- dry eye syndrome;

- epithelial-endothelial dystrophies of the cornea;

- children's age till 3 years;

- increased individual sensitivity to the components of the drug.

With caution should appoint a drug with increased blood pressure, CHD, arrhythmias, aneurysm, severe organic diseases of the heart and blood vessels, hyperthyroidism, pheochromocytoma, diabetes mellitus, during treatment with MAO inhibitors and other drugs that raise blood pressure, antidepressants, pregnancy and lactation breastfeeding).


Caution should be given to the preparation Octilia during pregnancy and lactation (breastfeeding).


The drug is contraindicated for children under 3 years.


The drug should not be used continuously for more than 4 days without consulting an ophthalmologist.

If within 2 days the symptoms of the disease persist or become more pronounced, an ophthalmologist should be consulted.

The drug should be stored out of the reach of children.
with its accidental ingestion, the development of a systemic action of the drug is possible.
Patients using contact lenses should only use Octillia with the lenses removed.
Install the lens can be 15 minutes after instillation of the drug.
The drug should not be used simultaneously with MAO inhibitors and within 10 days after discontinuation of their intake.


Symptoms: cyanosis, fever, convulsions, arrhythmias, cardiac arrest, increased blood pressure, pulmonary edema, dyspnea, CNS depression, accompanied by drowsiness, hypothermia, bradycardia, collapse, apnea and coma.

It should be borne in mind that the risk of overdose is high in young children, especially if swallowed.

Treatment: antidote is unknown.
Assign activated charcoal, gastric lavage, inhalation of oxygen, antipyretic and antiepileptic drugs.
To reduce blood pressure, phentolamine is prescribed in a dose of 5 mg slowly IV or 100 mg orally.


Patient interaction of the drug Octyly is not described.


List B. The drug should be stored out of reach of children at a temperature of no higher than 25 В° C.
Shelf life - 4 years. After opening the package, the drug should be stored for no more than 28 days.
Conditions of leave from pharmacies

The drug is released by prescription.

Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y

Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!